Cancer is a disease
characterized by uncontrolled growth of cell. There are about 100 different
types of cancer and each is classified by the type of cell where it occurs and
affects. Breast cancer is mostly prevalent in women, however, breast cancer
in men is rare. It is frequently diagnosed in aged women and one of the leading
causes of death among them. Some of the most common types of breast cancer are
ductal carcinoma in situ (DCIS), lobular carcinoma and invasive ductal
carcinoma.
DCIS, also known as
intraductal carcinoma, begins in the lining of the milk ducts. Milk ducts are thin
tubes carrying milk from lobules of the breast to the nipple. Lobule carcinoma
originates in the lobules or milk glands of the breast. Invasive ductal
carcinoma is the most common type of breast cancer. It starts in a milk duct of
the breast, ruptures through the wall of the duct and grows into the fatty
tissue of the breast. It spreads to other parts of body through bloodstream.
Request to Get the Sample Pages at:
North America accounts
the largest global breast cancer market followed by Europe. The U.S., followed
by Canada, is the largest market for breast cancer in North America. Key
driving factor for this market is increasing prevalence of breast cancer in the
region. Germany, France and the U.K. are some of the largest markets for breast
cancer in Europe region. However, Asia-Pacific represents the fastest growing
region in the global breast cancer market. This is due to improving healthcare
infrastructure and increasing awareness among people about breast cancer. In
developing countries, such as China and India, government has launched several
programs and initiatives which increase awareness about the disease. It has led
to significant rise in demand of breast cancer diagnostics and therapeutics for
disease management. In addition, less stringent wages and availability of
skilled labor attracts manufacturing companies to invest in developing
countries.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=-breast-cancer-market
Increasing prevalence of
the disease is a key driving factor for the global breast cancer market.
Increasing awareness among people about the disease and rising number of
geriatric women around the world are also supporting the growth of global
breast cancer market. In addition, increased research in the field of oncology
and development of biomarker has also fueled the growth of global breast cancer
market. Increasing demand of advanced therapeutic drugs and extensive drug
pipeline holds immense potential to the growth of the global breast cancer
market.
Some of the major
competitors in the market are Astrazeneca PLC, F. Hoffmann-La Roche Ltd, Eli
Lilly and Company, Novartis AG, Sanofi-Aventis. Pfizer, Inc., Bristol-Myers
Squibb Company, Bayer AG, GlaxoSmithKline plc and Teva Pharmaceutical
Industries Ltd.
